Article Versions Notes

Rodrigo MJ, Palomar APd, Montolío A, Mendez-Martinez S, Subias M, Cardiel MJ, Martinez-Rincon T, Cegoñino J, Fraile JM, Vispe E, et al. Monitoring New Long-Lasting Intravitreal Formulation for Glaucoma with Vitreous Images Using Optical Coherence Tomography. Pharmaceutics. 2021; 13(2):217. https://doi.org/10.3390/pharmaceutics13020217

Rodrigo, Maria Jesus, Amaya Pérez del Palomar, Alberto Montolío, Silvia Mendez-Martinez, Manuel Subias, Maria Jose Cardiel, Teresa Martinez-Rincon, José Cegoñino, José Maria Fraile, Eugenio Vispe, and et al. 2021. "Monitoring New Long-Lasting Intravitreal Formulation for Glaucoma with Vitreous Images Using Optical Coherence Tomography" Pharmaceutics 13, no. 2: 217. https://doi.org/10.3390/pharmaceutics13020217

Rodrigo, M. J., Palomar, A. P. d., Montolío, A., Mendez-Martinez, S., Subias, M., Cardiel, M. J., Martinez-Rincon, T., Cegoñino, J., Fraile, J. M., Vispe, E., Mayoral, J. A., Polo, V., & Garcia-Martin, E. (2021). Monitoring New Long-Lasting Intravitreal Formulation for Glaucoma with Vitreous Images Using Optical Coherence Tomography. Pharmaceutics, 13(2), 217. https://doi.org/10.3390/pharmaceutics13020217